GRP
ALDX icon

Global Retirement Partners’s Aldeyra Therapeutics ALDX Stock Holding History

Global Retirement Partners’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.3K Buy
+10,000
New +$17.2K ﹤0.01% 3021
2025
Q4 		$51.8K Buy
+10,000
New +$51.4K ﹤0.01% 2327

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Global Retirement Partners's ALDX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Aldeyra Therapeutics (ALDX) in Q2 2026: 10,000 shares worth $21.3K. The stake represents ﹤0.01% of the portfolio and ranks #3021 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in ALDX as recently as Q4 2025.

Global Retirement Partners first reported a position in ALDX in Q4 2025 and has held it in 2 quarters since. The position peaked at $51.8K in Q4 2025. 107 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • Global Retirement Partners held 10,000 shares of Aldeyra Therapeutics worth $21.3K as of Q2 2026.
  • Aldeyra Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • Aldeyra Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3021 holding.
  • Global Retirement Partners first reported a position in Aldeyra Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Global Retirement Partners's Aldeyra Therapeutics position peaked at $51.8K in Q4 2025.
  • 107 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.